Allied Market Research published a report on the glycomics/glycobiology sector, which offers industry dynamics, including growth drivers, opportunities, and challenges. This report provides a competitive landscape of the sector. The global glycomics/glycobiology market size was valued at $2.0 billion in 2023, and is projected to reach $7.8 billion by 2033, growing at a CAGR of 14.5% from 2024 to 2033.
Glycomics is the study of glycomes of an organism, which is the complete set of all sugars, whether free or bound in complex molecules. Glycobiology studies the structure, biological functions, and biosynthesis of sugars in biological processes. Thus, glycomics is a subset of glycobiology.
► Don't Miss Out “Download Your Exclusive Sample PDF Report” Now:
https://www.alliedmarketresearch.com/request-sample/A324428
The different chains of sugars are termed glycans. They have different properties and are among the most important molecules in cell biology. They play critical roles during normal cell functions and in diseases as well. Numerous advancements in the field of glycomics have led to breakthroughs regarding glycome and its complexities. There is ongoing research about changes in glycan structure in various diseases, stages of diseases, traits and prognosis, changes in cells, and age-related physiology, which is expected to reveal critical insights about disease development and progression.
Thus, both glycomics and glycobiology are expected to have a wide range of applications in biotechnology, biomedical research, diagnostics, drug discovery and development, immunology, oncology, and various other sectors.
Rise in R&D investments by pharmaceutical and biotech companies and surge in the proteomics market are the major drivers of the glycomics/glycobiology market. Various investments in research by numerous governments and drug development are leading to technological advancements, which are expected to boost market growth. Glycomics and proteomics research is an emerging field and is gaining attention, which is expected to fuel the expansion of the glycomics/glycobiology market.
Although the high costs of the tool required for glycomics/glycobiology research is a major challenge, different research organizations are engaging in academic research to develop innovative and affordable tools. Innovations such as HPLC and mass spectrometry in chemical and biological research provide extremely sensitive and rapid results. In addition, a rise in demand for medicines to treat severe chronic diseases has led to an increase in R&D investments and a rise in collaborations between research institutes and major organizations. This is expected to pave the way to increase the understanding of cell biology and overall human health.
Important questions
What are the key factors driving the growth of this industry?
Which companies are the leading players in the domain?
Which region leads the glycomics/glycobiology market?
What are the factors that restrain the growth of the sector?
Key benefits for stakeholders
The report offers an in-depth analysis of market segments, prevailing trends, forecasts, and dynamics within the global glycomics/glycobiology market from 2023 to 2032, with a primary focus on identifying business opportunities. The research report studies the market by utilizing tools such as drivers & restraints impact analysis, value chain analysis, Porter’s five forces analysis, opportunity map analysis, and the market attractiveness index to provide a well-studied market assessment.
In addition, the research analyzes key players in the global glycomics/glycobiology market, and offers insights into their company profiles, market strategies, and supply-demand dynamics. It evaluates the competitive landscape, thus helping stakeholders identify potential partners or rivals.
List of Key players
Major key players operating in the global glycomics/glycobiology market include:
Agilent Technologies
Lectenz Bio
Waters Corporation
Merck KGaA
Takara Bio
ProZyme
S Bio.
Shimadzu Corporation
Thermo Fisher Scientific Inc.
New England Biolabs
These players have adopted different strategies, such as agreement, acquisition, product launch, and product approval to sustain their foothold and improve the product portfolio of the glycomics/glycobiology market.
To sum up
The AMR report offers a detailed study of the glycomics/glycobiology industry, including a comprehensive competitive landscape. It further highlights key growth drivers, trends, and potential opportunities that empower leading key players in the industry and major stakeholders to make informed strategic decisions. The report serves as a valuable resource for understanding changes in the sector by mitigating risks and supporting long-term business growth by offering in-depth insights in an increasingly competitive environment.
Contact Us:
United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
